BioStable develops innovative new products for the treatment of cardiovascular diseases. Founded by Al Beavan, Don James, J. Scott Rankin, and Rusty Phillips in 2008, BioStable is backed by investors that include Maryland Momentum Fund and is headquartered in Austin.